|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 354 for Fgf23

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.044s

Categories

Category: Publication
Type Details Score
Publication
First Author: ADHR Consortium.
Year: 2000
Journal: Nat Genet
Title: Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.
Volume: 26
Issue: 3
Pages: 345-8
Publication
First Author: Ornitz DM
Year: 2001
Journal: Genome Biol
Title: Fibroblast growth factors.
Volume: 2
Issue: 3
Pages: REVIEWS3005
Publication
First Author: Faul C
Year: 2011
Journal: J Clin Invest
Title: FGF23 induces left ventricular hypertrophy.
Volume: 121
Issue: 11
Pages: 4393-408
Publication
First Author: Liu S
Year: 2006
Journal: Am J Physiol Endocrinol Metab
Title: Pathogenic role of Fgf23 in Hyp mice.
Volume: 291
Issue: 1
Pages: E38-49
Publication
First Author: Liu S
Year: 2008
Journal: Am J Physiol Endocrinol Metab
Title: Pathogenic role of Fgf23 in Dmp1-null mice.
Volume: 295
Issue: 2
Pages: E254-61
Publication  
First Author: Courbon G
Year: 2023
Journal: JCI Insight
Title: FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice.
Volume: 8
Issue: 24
Publication
First Author: Ichikawa S
Year: 2014
Journal: Endocrinology
Title: Genetic rescue of glycosylation-deficient Fgf23 in the Galnt3 knockout mouse.
Volume: 155
Issue: 10
Pages: 3891-8
Publication
First Author: Tamamura Y
Year: 2019
Journal: Biochem Biophys Res Commun
Title: Notch signaling is involved in Fgf23 upregulation in osteocytes.
Volume: 518
Issue: 2
Pages: 233-238
Publication
First Author: Meo Burt P
Year: 2018
Journal: Endocrinology
Title: FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2.
Volume: 159
Issue: 6
Pages: 2386-2396
Publication
First Author: Liu S
Year: 2009
Journal: Mol Endocrinol
Title: Novel regulators of Fgf23 expression and mineralization in Hyp bone.
Volume: 23
Issue: 9
Pages: 1505-18
Publication
First Author: Onishi T
Year: 2008
Journal: Arch Oral Biol
Title: Phex mutation causes overexpression of FGF23 in teeth.
Volume: 53
Issue: 2
Pages: 99-104
Publication
First Author: Simic P
Year: 2020
Journal: J Clin Invest
Title: Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney.
Volume: 130
Issue: 3
Pages: 1513-1526
Publication
First Author: Li Y
Year: 2013
Journal: Calcif Tissue Int
Title: FGF23 affects the lineage fate determination of mesenchymal stem cells.
Volume: 93
Issue: 6
Pages: 556-64
Publication  
First Author: Xiao Z
Year: 2019
Journal: JCI Insight
Title: FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.
Volume: 4
Issue: 23
Publication
First Author: Umbach AT
Year: 2016
Journal: Kidney Blood Press Res
Title: Impact of Annexin A 7 Deficiency on FGF23 Plasma Concentrations.
Volume: 41
Issue: 6
Pages: 828-836
Publication
First Author: Smith RC
Year: 2012
Journal: J Clin Invest
Title: Circulating αKlotho influences phosphate handling by controlling FGF23 production.
Volume: 122
Issue: 12
Pages: 4710-5
Publication
First Author: Andrukhova O
Year: 2014
Journal: EMBO J
Title: FGF23 promotes renal calcium reabsorption through the TRPV5 channel.
Volume: 33
Issue: 3
Pages: 229-46
Publication
First Author: Andrukhova O
Year: 2014
Journal: EMBO Mol Med
Title: FGF23 regulates renal sodium handling and blood pressure.
Volume: 6
Issue: 6
Pages: 744-59
Publication  
First Author: Andrukhova O
Year: 2016
Journal: Mol Cell Endocrinol
Title: Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Volume: 436
Pages: 224-39
Publication
First Author: Bai X
Year: 2009
Journal: Am J Physiol Endocrinol Metab
Title: Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
Volume: 296
Issue: 1
Pages: E79-88
Publication
First Author: Shimada T
Year: 2004
Journal: J Clin Invest
Title: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.
Volume: 113
Issue: 4
Pages: 561-8
Publication
First Author: Kaludjerovic J
Year: 2017
Journal: FASEB J
Title: Klotho expression in long bones regulates FGF23 production during renal failure.
Volume: 31
Issue: 5
Pages: 2050-2064
Publication
First Author: Daryadel A
Year: 2021
Journal: FASEB J
Title: Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage.
Volume: 35
Issue: 2
Pages: e21302
Publication
First Author: Kawai M
Year: 2014
Journal: J Biol Chem
Title: Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner.
Volume: 289
Issue: 3
Pages: 1457-66
Publication
First Author: Lindberg K
Year: 2013
Journal: PLoS One
Title: Arterial klotho expression and FGF23 effects on vascular calcification and function.
Volume: 8
Issue: 4
Pages: e60658
Publication
First Author: Yu X
Year: 2005
Journal: Bone
Title: Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations.
Volume: 36
Issue: 6
Pages: 971-7
Publication
First Author: Karaplis AC
Year: 2012
Journal: Endocrinology
Title: Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice.
Volume: 153
Issue: 12
Pages: 5906-17
Publication
First Author: Fukuda T
Year: 2007
Journal: Biochem Biophys Res Commun
Title: FGF23 induces expression of two isoforms of NAB2, which are corepressors of Egr-1.
Volume: 353
Issue: 1
Pages: 147-51
Publication  
First Author: Clinkenbeard EL
Year: 2019
Journal: JCI Insight
Title: Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
Volume: 4
Issue: 4
Publication
First Author: Lysaght AC
Year: 2014
Journal: PLoS One
Title: FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice.
Volume: 9
Issue: 9
Pages: e107681
Publication
First Author: Clinkenbeard EL
Year: 2014
Journal: J Bone Miner Res
Title: Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice.
Volume: 29
Issue: 2
Pages: 361-9
Publication
First Author: Hollberg K
Year: 2008
Journal: Bone
Title: Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Volume: 42
Issue: 6
Pages: 1111-21
Publication
First Author: Quarles LD
Year: 2012
Journal: Nat Rev Endocrinol
Title: Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.
Volume: 8
Issue: 5
Pages: 276-86
Publication  
First Author: Jüppner H
Year: 2011
Journal: Kidney Int Suppl
Title: Phosphate and FGF-23.
Issue: 121
Pages: S24-7
Publication
First Author: Fukumoto S
Year: 2008
Journal: Intern Med
Title: Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
Volume: 47
Issue: 5
Pages: 337-43
Publication
First Author: Bowe AE
Year: 2001
Journal: Biochem Biophys Res Commun
Title: FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.
Volume: 284
Issue: 4
Pages: 977-81
Publication
First Author: Aprile A
Year: 2023
Journal: Sci Transl Med
Title: Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia.
Volume: 15
Issue: 698
Pages: eabq3679
Publication
First Author: Slavic S
Year: 2017
Journal: Sci Rep
Title: Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload.
Volume: 7
Issue: 1
Pages: 11298
Publication
First Author: Inoue Y
Year: 2005
Journal: Biochem J
Title: Role of the vitamin D receptor in FGF23 action on phosphate metabolism.
Volume: 390
Issue: Pt 1
Pages: 325-31
Publication  
First Author: Radhakrishnan K
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injury.
Volume: 118
Issue: 16
Publication  
First Author: Matthias J
Year: 2020
Journal: Endocrinology
Title: Extra-Large Gα Protein (XLαs) Deficiency Causes Severe Adenine-Induced Renal Injury with Massive FGF23 Elevation.
Volume: 161
Issue: 1
Publication
First Author: Fan Y
Year: 2016
Journal: FASEB J
Title: Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.
Volume: 30
Issue: 1
Pages: 428-40
Publication
First Author: Masuyama R
Year: 2006
Journal: J Clin Invest
Title: Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Volume: 116
Issue: 12
Pages: 3150-9
Publication
First Author: Shimada T
Year: 2005
Journal: Am J Physiol Renal Physiol
Title: Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism.
Volume: 289
Issue: 5
Pages: F1088-95
Publication
First Author: Olauson H
Year: 2013
Journal: PLoS Genet
Title: Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion.
Volume: 9
Issue: 12
Pages: e1003975
Publication
First Author: Bøllehuus Hansen L
Year: 2020
Journal: FASEB J
Title: Influence of FGF23 and Klotho on male reproduction: Systemic vs direct effects.
Volume: 34
Issue: 9
Pages: 12436-12449
Publication  
First Author: Jung YS
Year: 2024
Journal: Redox Biol
Title: ERRγ-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress.
Volume: 71
Pages: 103107
Publication
First Author: Dai B
Year: 2012
Journal: PLoS One
Title: A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.
Volume: 7
Issue: 9
Pages: e44161
Publication
First Author: Touchberry CD
Year: 2013
Journal: Am J Physiol Endocrinol Metab
Title: FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.
Volume: 304
Issue: 8
Pages: E863-73
Publication
First Author: Silswal N
Year: 2014
Journal: Am J Physiol Endocrinol Metab
Title: FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.
Volume: 307
Issue: 5
Pages: E426-36
Publication
First Author: Murali SK
Year: 2016
Journal: PLoS Biol
Title: Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Volume: 14
Issue: 4
Pages: e1002427
Publication
First Author: Kawai M
Year: 2013
Journal: J Biol Chem
Title: FGF23 suppresses chondrocyte proliferation in the presence of soluble α-Klotho both in vitro and in vivo.
Volume: 288
Issue: 4
Pages: 2414-27
Publication
First Author: Murali SK
Year: 2016
Journal: J Bone Miner Res
Title: FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner.
Volume: 31
Issue: 1
Pages: 129-42
Publication
First Author: Kamiya N
Year: 2017
Journal: J Bone Miner Res
Title: Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.
Volume: 32
Issue: 8
Pages: 1716-1726
Publication  
First Author: Reilly AM
Year: 2014
Journal: Bone
Title: Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium.
Volume: 67
Pages: 139-44
Publication
First Author: Gattineni J
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4.
Volume: 306
Issue: 3
Pages: F351-8
Publication
First Author: Wang X
Year: 2012
Journal: PLoS Genet
Title: Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice.
Volume: 8
Issue: 5
Pages: e1002708
Publication
First Author: Flamme I
Year: 2017
Journal: PLoS One
Title: FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase.
Volume: 12
Issue: 10
Pages: e0186979
Publication  
First Author: Sellars KB
Year: 2021
Journal: Endocrinology
Title: Murine Fetal Serum Phosphorus is Set Independent of FGF23 and PTH, Except in the Presence of Maternal Phosphate Loading.
Volume: 162
Issue: 1
Publication
First Author: Goetz R
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
Volume: 107
Issue: 1
Pages: 407-12
Publication
First Author: Sakurai A
Year: 2017
Journal: Biomed Res
Title: Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone.
Volume: 38
Issue: 4
Pages: 257-267
Publication
First Author: Wu X
Year: 2012
Journal: J Mol Biol
Title: A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Volume: 418
Issue: 1-2
Pages: 82-9
Publication
First Author: Andrukhova O
Year: 2012
Journal: Bone
Title: FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway.
Volume: 51
Issue: 3
Pages: 621-8
Publication
First Author: Liu ES
Year: 2018
Journal: Endocrinology
Title: Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.
Volume: 159
Issue: 5
Pages: 2165-2172
Publication
First Author: Takashi Y
Year: 2019
Journal: Proc Natl Acad Sci U S A
Title: Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation.
Volume: 116
Issue: 23
Pages: 11418-11427
Publication
First Author: Egli-Spichtig D
Year: 2021
Journal: Sci Rep
Title: Renal Dnase1 expression is regulated by FGF23 but loss of Dnase1 does not alter renal phosphate handling.
Volume: 11
Issue: 1
Pages: 6175
Publication
First Author: Ma Y
Year: 2014
Journal: Endocrinology
Title: Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization.
Volume: 155
Issue: 5
Pages: 1596-605
Publication
First Author: Streicher C
Year: 2012
Journal: Endocrinology
Title: Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.
Volume: 153
Issue: 4
Pages: 1795-805
Publication
First Author: Stubbs JR
Year: 2012
Journal: J Bone Miner Res
Title: Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
Volume: 27
Issue: 1
Pages: 38-46
Publication
First Author: Ichikawa S
Year: 2009
Journal: Endocrinology
Title: Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.
Volume: 150
Issue: 6
Pages: 2543-50
Publication
First Author: Xiao L
Year: 2010
Journal: J Biol Chem
Title: Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Volume: 285
Issue: 4
Pages: 2834-46
Publication
First Author: Ma Y
Year: 2017
Journal: Endocrinology
Title: FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.
Volume: 158
Issue: 2
Pages: 252-263
Publication
First Author: Martin A
Year: 2012
Journal: Mol Endocrinol
Title: Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Volume: 26
Issue: 11
Pages: 1883-95
Publication
First Author: Gattineni J
Year: 2009
Journal: Am J Physiol Renal Physiol
Title: FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.
Volume: 297
Issue: 2
Pages: F282-91
Publication
First Author: Liu S
Year: 2007
Journal: Am J Physiol Endocrinol Metab
Title: Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Volume: 293
Issue: 6
Pages: E1636-44
Publication
First Author: Liu ES
Year: 2016
Journal: J Bone Miner Res
Title: 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
Volume: 31
Issue: 5
Pages: 929-39
Publication  
First Author: Burgess WH
Year: 1989
Journal: Annu Rev Biochem
Title: The heparin-binding (fibroblast) growth factor family of proteins.
Volume: 58
Pages: 575-606
Publication
First Author: Wilkie AO
Year: 1995
Journal: Curr Biol
Title: Functions of fibroblast growth factors and their receptors.
Volume: 5
Issue: 5
Pages: 500-7
Publication
First Author: Thomas KA
Year: 1988
Journal: Trends Biochem Sci
Title: Transforming potential of fibroblast growth factor genes.
Volume: 13
Issue: 9
Pages: 327-8
Publication
First Author: Plotnikov AN
Year: 2000
Journal: Cell
Title: Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
Volume: 101
Issue: 4
Pages: 413-24
Publication
First Author: Blaber M
Year: 1996
Journal: Biochemistry
Title: X-ray crystal structure of human acidic fibroblast growth factor.
Volume: 35
Issue: 7
Pages: 2086-94
Publication
First Author: Vlodavsky I
Year: 1990
Journal: Cancer Metastasis Rev
Title: Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis.
Volume: 9
Issue: 3
Pages: 203-26
Publication
First Author: Green PJ
Year: 1996
Journal: Bioessays
Title: Promiscuity of fibroblast growth factor receptors.
Volume: 18
Issue: 8
Pages: 639-46
Publication
First Author: Yardley N
Year: 2012
Journal: Dev Biol
Title: FGF signaling transforms non-neural ectoderm into neural crest.
Volume: 372
Issue: 2
Pages: 166-77
Publication
First Author: Böttcher RT
Year: 2005
Journal: Endocr Rev
Title: Fibroblast growth factor signaling during early vertebrate development.
Volume: 26
Issue: 1
Pages: 63-77
Publication
First Author: Koga C
Year: 1999
Journal: Biochem Biophys Res Commun
Title: Characterization of a novel member of the FGF family, XFGF-20, in Xenopus laevis.
Volume: 261
Issue: 3
Pages: 756-65
Publication
First Author: Nakamizo S
Year: 2013
Journal: Skin Pharmacol Physiol
Title: Topical treatment with basic fibroblast growth factor promotes wound healing and barrier recovery induced by skin abrasion.
Volume: 26
Issue: 1
Pages: 22-9
Publication
First Author: Kumar SB
Year: 2013
Journal: Curr Pharm Des
Title: Fibroblast growth factor receptor inhibitors.
Volume: 19
Issue: 4
Pages: 687-701
Publication
First Author: Amaya E
Year: 1991
Journal: Cell
Title: Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos.
Volume: 66
Issue: 2
Pages: 257-70
Publication
First Author: Borland CZ
Year: 2001
Journal: Bioessays
Title: Fibroblast growth factor signaling in Caenorhabditis elegans.
Volume: 23
Issue: 12
Pages: 1120-30
Publication
First Author: Coumoul X
Year: 2003
Journal: Birth Defects Res C Embryo Today
Title: Roles of FGF receptors in mammalian development and congenital diseases.
Volume: 69
Issue: 4
Pages: 286-304
Publication
First Author: Sutherland D
Year: 1996
Journal: Cell
Title: branchless encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching.
Volume: 87
Issue: 6
Pages: 1091-101
Publication
First Author: Bai X
Year: 2004
Journal: Endocrinology
Title: Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
Volume: 145
Issue: 11
Pages: 5269-79
Publication
First Author: Lee SM
Year: 2019
Journal: Endocrinology
Title: A Control Region Near the Fibroblast Growth Factor 23 Gene Mediates Response to Phosphate, 1,25(OH)2D3, and LPS In Vivo.
Volume: 160
Issue: 12
Pages: 2877-2891
Publication
First Author: Bai X
Year: 2016
Journal: J Clin Invest
Title: CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders.
Volume: 126
Issue: 2
Pages: 667-80
Publication
First Author: Farrow EG
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice.
Volume: 108
Issue: 46
Pages: E1146-55
Publication
First Author: Stubbs JR
Year: 2007
Journal: J Am Soc Nephrol
Title: Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.
Volume: 18
Issue: 7
Pages: 2116-24
Publication  
First Author: Weidner H
Year: 2020
Journal: JCI Insight
Title: Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.
Volume: 5
Issue: 15
Publication
First Author: Knab VM
Year: 2017
Journal: Endocrinology
Title: Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels.
Volume: 158
Issue: 5
Pages: 1130-1139
Publication
First Author: Agoro R
Year: 2018
Journal: FASEB J
Title: Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.
Volume: 32
Issue: 7
Pages: 3752-3764